Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 1 (1 total).

Gonzales J. 2021. New Mexico evidence-informed policy track submission. [Washington, DC]: Association of Maternal and Child Health Programs, Innovation Hub,

Annotation: This video details New Mexico's journey in developing comprehensive policies for substance-exposed newborns, specifically highlighting how the state worked to align with the 2016 Comprehensive Addiction and Recovery Act (CARA)'s amendments to the Child Abuse Prevention and Treatment Act (CAPTA). The process culminated in the 2019 passage of HB230, which mandates hospitals to create Plans of Care for affected infants and families, with the Children, Youth and Families Department (CYFD) providing guidance to hospitals, insurers, and other stakeholders. Length: 8 minutes, 25 seconds.

Contact: Association of Maternal and Child Health Programs, 1825 K Street, N.W., Suite 250, Washington, DC 20006-1202, Telephone: (202) 775-0436 Fax: (202) 478-5120 E-mail: [email protected] Web Site: http://www.amchp.org

Keywords: New Mexico, Patient care planning, Substance abusing pregnant women, Substance exposed infants, Substance abusing women, State policies, Evaluation, Title V programs
   

The MCH Digital Library is one of six special collections at Geogetown University, the nation's oldest Jesuit institution of higher education. It is supported in part by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under award number U02MC31613, MCH Advanced Education Policy with an award of $700,000/year. The library is also supported through foundation and univerity funding. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.